Take-Home Messages

View at publisher Summarise with VIRAT
Authors: Robert Hudak
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Treatment resistance is common in OCD. Approximately 40% to 60% of patients meet criteria for treatment resistance despite an integrated approach. SSRIs remain the pharmacologic treatment of choice for OCD, even after multiple SSRI failures. OCD guidelines recommend using them at doses above FDA recommendations. The recommended sequence for augmenting OCD treatment starts with clomipramine as first option, followed by glutamatergic agents and then second-generation antipsychotics if needed.

Fields of Study & Subjects

Obsessive-Compulsive Spectrum Disorders Anxiety Depression Psychometrics Treatment Cognitive Processes Psychoanalysis and Psychopathology Research

Publication details

Publication date
1 February 2026
Language
EN